Bausch Health Companies (BHC) executive compensation, 2026 proxy

Thomas J. Appio, Chief Executive Officer, was paid $16.9M in 2025, up 4% from $16.2M the year before. The CEO-to-median-employee pay ratio was 401:1, on median employee pay of $42,062.

Filed
April 8, 2026
Annual meeting
May 19, 2026
Pay year
2025
Named executives
4
CEO total pay
$16.9M+4% vs prior year
CEO to median employee
401:1median $42,062
CEO pay in equity
77%$13M in awards
CEO Base Salary
$1,236,000For fiscal year 2025
CEO Non-Equity Incentive
$2,336,000AIP payout for 2025
Median Employee Pay
$42,062Annual total compensation
CEO to Median Pay Ratio
401:1For fiscal 2025

How Appio was paid

$16.9M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary7%Bonus1%Stock awards77%Non-equity incentive14%All other compensation0%

Named executive officers

ExecutiveTotal
Thomas J. AppioChief Executive Officer$16,877,326
Jean-Jacques CharhonExecutive Vice President, Chief Financial Officer$4,905,075
Seana CarsonExecutive Vice President, General Counsel$4,261,607
Aimee J. LenarExecutive Vice President, US Pharma$3,264,491

What changed and why

  • $16.9MChief Executive Officer Thomas J. Appio received total compensation of $16,877,326 in fiscal 2025.
  • 3.9%CEO total compensation increased by approximately 3.9% compared to the prior fiscal year total of $16,239,133.
  • The ratio of the annual total compensation of the CEO to the median employee was 401 to 1.
  • $42,062The median employee annual total compensation was calculated as $42,062 for 2025.
  • $13MStock awards for the CEO were valued at $13,032,562 based on grant date fair value.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.